Almoosa Health Company (TADAWUL:4018)
Saudi Arabia · Delayed Price · Currency is SAR 118.40
+7.20 (6.47%)
May 21, 2026, 3:19 PM AST
Almoosa Health Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 192.84 | 236.54 | 49.35 | 98.15 | 51.02 | 62.42 |
Depreciation & Amortization | 99.8 | 94.6 | 81.73 | 64.76 | 56.94 | 28.49 |
Other Amortization | 2.29 | 2.29 | 2.62 | 3.53 | 2.65 | 1.46 |
Loss (Gain) From Sale of Assets | -0.21 | -0.22 | -0.11 | -0.33 | -0.03 | 0.07 |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.01 | 0.01 |
Loss (Gain) From Sale of Investments | 4.18 | 6.36 | - | - | - | - |
Loss (Gain) on Equity Investments | -0.59 | -0.54 | -1.19 | - | - | - |
Provision & Write-off of Bad Debts | 7.35 | 6.84 | 4.41 | 3.93 | -0.17 | 1.22 |
Other Operating Activities | 20.17 | -17.16 | 70.45 | 10.36 | 14.93 | 12.08 |
Change in Accounts Receivable | -197.4 | -138.17 | -42.3 | -166.81 | -66.22 | -10.71 |
Change in Inventory | -9 | -9.95 | -8.81 | -9.29 | -0.16 | -7.77 |
Change in Accounts Payable | 34.78 | -17.36 | -1.1 | 3.15 | -49.76 | 75.25 |
Change in Other Net Operating Assets | 38.35 | 17.58 | -15.38 | 32.62 | -20.19 | 35.21 |
Operating Cash Flow | 192.56 | 180.83 | 139.67 | 40.07 | -10.97 | 197.72 |
Operating Cash Flow Growth | 65.80% | 29.47% | 248.56% | - | - | 31.88% |
Capital Expenditures | -571.68 | -465.1 | -196.32 | -383.19 | -307.18 | -318.47 |
Sale of Property, Plant & Equipment | 2.64 | 2.65 | 1.36 | 23.07 | 0.03 | 0.02 |
Sale (Purchase) of Intangibles | -5.86 | -3.14 | -6.33 | -2.16 | -2.89 | -0.31 |
Sale (Purchase) of Real Estate | -62.79 | -62.79 | -16.93 | -92.1 | - | - |
Investment in Securities | 61.35 | -88.65 | - | - | - | 3.28 |
Investing Cash Flow | -576.34 | -617.03 | -218.22 | -454.39 | -310.04 | -315.49 |
Long-Term Debt Issued | - | 127 | 305.59 | 622.91 | 285.67 | 148.91 |
Long-Term Debt Repaid | - | -745.51 | -190.67 | -208 | -7.54 | -7.54 |
Total Debt Repaid | -16.83 | -745.51 | -190.67 | -208 | -7.54 | -7.54 |
Net Debt Issued (Repaid) | 266.17 | -618.51 | 114.92 | 414.92 | 278.13 | 141.38 |
Issuance of Common Stock | - | 1,182 | - | - | - | - |
Common Dividends Paid | -86.39 | -86.39 | -14.01 | - | - | -15.66 |
Other Financing Activities | -0.26 | -40.38 | - | - | - | - |
Financing Cash Flow | 179.51 | 436.27 | 100.92 | 414.92 | 278.13 | 125.71 |
Net Cash Flow | -204.26 | 0.07 | 22.36 | 0.6 | -42.88 | 7.94 |
Free Cash Flow | -379.12 | -284.27 | -56.66 | -343.12 | -318.15 | -120.76 |
Free Cash Flow Margin | -26.30% | -20.07% | -4.71% | -35.05% | -38.99% | -17.21% |
Free Cash Flow Per Share | -8.55 | -6.44 | -1.62 | -9.80 | -9.09 | -1207.55 |
Cash Interest Paid | 20.48 | 20.48 | 78.55 | 24.02 | 10 | 1.14 |
Levered Free Cash Flow | -435.79 | -354.84 | -68.71 | -369.73 | -359.89 | -122.63 |
Unlevered Free Cash Flow | -426.9 | -344.14 | -19.4 | -357.82 | -351.6 | -121.7 |
Change in Working Capital | -133.27 | -147.89 | -67.58 | -140.33 | -136.33 | 91.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.